OBJECTIVE: To report a patient with Parkinson disease (PD) who developed zoophilia as a possible complication of dopaminergic therapy. CASE SUMMARY: A 74-year-old man with advanced PD, who had wearing-off motor fluctuations, with a marked disability during the off periods and severe peak-of-dose choreiform dyskinesias, developed hypersexuality with zoophilia 5 days after standard levodopa was substituted for controlled-release levodopa and the dose of bromocriptine was increased. The abnormal sexual behavior disappeared 2 days after the doses of standard levodopa and of bromocriptine were reduced. DISCUSSION: Hypersexuality is a known complication in PD patients undergoing dopaminergic therapy. However, the possible development of zoophilia due to these drugs, as was the case in our patient, is exceptional. CONCLUSIONS: Zoophilia should be considered as a possible behavioral complication of dopaminergic therapy in PD patients.
OBJECTIVE: To report a patient with Parkinson disease (PD) who developed zoophilia as a possible complication of dopaminergic therapy. CASE SUMMARY: A 74-year-old man with advanced PD, who had wearing-off motor fluctuations, with a marked disability during the off periods and severe peak-of-dose choreiform dyskinesias, developed hypersexuality with zoophilia 5 days after standard levodopa was substituted for controlled-release levodopa and the dose of bromocriptine was increased. The abnormal sexual behavior disappeared 2 days after the doses of standard levodopa and of bromocriptine were reduced. DISCUSSION: Hypersexuality is a known complication in PDpatients undergoing dopaminergic therapy. However, the possible development of zoophilia due to these drugs, as was the case in our patient, is exceptional. CONCLUSIONS: Zoophilia should be considered as a possible behavioral complication of dopaminergic therapy in PDpatients.
Authors: Michael K Scullin; Ann B Sollinger; Julia Land; Cathy Wood-Siverio; Lavezza Zanders; Raven Lee; Alan Freeman; Felicia C Goldstein; Donald L Bliwise; Stewart A Factor Journal: Parkinsonism Relat Disord Date: 2013-07-21 Impact factor: 4.891
Authors: Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras Journal: J Neurol Date: 2014-05-14 Impact factor: 4.849
Authors: J Michael Bostwick; Kathleen A Hecksel; Susanna R Stevens; James H Bower; J Eric Ahlskog Journal: Mayo Clin Proc Date: 2009-04 Impact factor: 7.616